Luo You-You, Fang You-Hong, Yu Jin-Dan, Xu Luo-Jia, Sun Ming-Fang, Cheng Qi, Chen Jie
Department of Gastroenterology, Children's Hospital, Zhejiang University School of Medicine/National Clinical Research Center for Child Health, Hangzhou 310052, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jun 15;24(6):626-630. doi: 10.7499/j.issn.1008-8830.2201065.
To evaluate the effectiveness of induction therapy with exclusive enteral nutrition (EEN) in pediatric Crohn's disease (CD).
A retrospective analysis was performed on the medical data of 62 children with CD who received EEN in Children's Hospital, Zhejiang University School of Medicine, from March 2013 to August 2021. The medical data included general information and height, weight, Pediatric Crohn's Disease Activity Index (PCDAI), Crohn's Disease Endoscopic Index of Severity, C-reactive protein, erythrocyte sedimentation rate, and serum albumin level before treatment and after 8 weeks of treatment. The changes in the above indicators were compared before and after treatment.
Among the 62 children with CD, there were 39 boys (63%) and 23 girls (37%), with a mean age of (11.9±3.0) years at diagnosis. Among the 55 children who completed EEN treatment for at least 8 weeks, 48 (87%) achieved clinical remission at week 8. PCDAI at week 8 was significantly lower than that before treatment (<0.001). Except for 17 children with involvement of the small intestine alone and 3 children with involvement of the colon who did not receive colonoscopy reexamination, the remaining 35 children with involvement of the colon received colonoscopy reexamination after the 8-week EEN treatment. Of the 35 children, 29 (83%) achieved mucosal healing. As for the 48 children who achieved clinical remission at week 8, there were significant improvements in height-for-age Z-score and body mass index-for-age Z-score at week 8 (<0.01). As for the 7 children who did not achieve clinical remission at week 8, there were no significant changes in height-for-age Z-score and body mass index-for-age Z-score at week 8 (>0.05).
The 8-week EEN treatment has a good effect on clinical remission and mucosal healing in children with CD. For the children with CD achieving clinical remission, EEN can improve their height and body mass index.
评估全肠内营养(EEN)诱导治疗小儿克罗恩病(CD)的有效性。
对2013年3月至2021年8月在浙江大学医学院附属儿童医院接受EEN治疗的62例CD患儿的医疗数据进行回顾性分析。医疗数据包括一般信息以及治疗前和治疗8周后的身高、体重、小儿克罗恩病活动指数(PCDAI)、克罗恩病内镜严重程度指数、C反应蛋白、红细胞沉降率和血清白蛋白水平。比较治疗前后上述指标的变化。
62例CD患儿中,男39例(63%),女23例(37%),诊断时平均年龄为(11.9±3.0)岁。在至少完成8周EEN治疗的55例患儿中,48例(87%)在第8周达到临床缓解。第8周时的PCDAI显著低于治疗前(<0.001)。除17例仅累及小肠的患儿和3例累及结肠但未接受结肠镜复查的患儿外,其余35例累及结肠的患儿在8周EEN治疗后接受了结肠镜复查。在这35例患儿中,29例(83%)实现了黏膜愈合。对于在第8周达到临床缓解的48例患儿,第8周时年龄别身高Z评分和年龄别体重指数Z评分有显著改善(<0.01)。对于在第8周未达到临床缓解的7例患儿,第8周时年龄别身高Z评分和年龄别体重指数Z评分无显著变化(>0.05)。
8周的EEN治疗对CD患儿的临床缓解和黏膜愈合有良好效果。对于实现临床缓解的CD患儿,EEN可改善其身高和体重指数。